Kevin N. Heller
Plus aucun poste en cours
Profil
Kevin N.
Heller worked as a Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He then worked as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
From 2018 to 2020, he served as Chief Medical Officer at NextCure, Inc. In 2021, he worked as Executive Vice President-Research & Development at Jasper Therapeutics, Inc. Dr. Heller holds a doctorate degree from George Washington University and an undergraduate degree from Yale University.
Anciens postes connus de Kevin N. Heller
| Sociétés | Poste | Fin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/03/2022 |
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 04/08/2020 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/04/2018 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01/05/2015 |
Formation de Kevin N. Heller
| George Washington University | Doctorate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
